GABA levels within the medial preoptic area: effects of chronic administration of sodium valproic acid

• Published in: Psychoneuroendocrinology Vol. 25; no. 5; pp. 519 - 534
• Main Authors: Dodge, James C., Illig, Amanda M., Snyder, Peter J., Badura, Lori L.
• Format: Journal Article
• Language: English
• Published: Oxford Elsevier Ltd 01.07.2000; Elsevier
• Subjects: Animals; Behavioral psychophysiology; Biological and medical sciences; Chromatography, High Pressure Liquid; Estrous cyclicity; Estrus; Female; Fundamental and applied biological sciences. Psychology; GABA Agents - administration & dosage; GABA Agents - pharmacology; gamma-Aminobutyric Acid - metabolism; GnRH; HPLC; Male; Mice; Mice, Inbred DBA; Microdialysis; Neurotransmission and behavior; Preoptic Area - drug effects; Preoptic Area - metabolism; Psychology. Psychoanalysis. Psychiatry; Psychology. Psychophysiology; Seizures; Valproic Acid - administration & dosage; Valproic Acid - pharmacology; Microdialysis; GnRH; HPLC; Seizures; Estrous cyclicity; Rodentia; Gonadotropin RH; Anticonvulsant; Valproic acid; Gabaergic pathway; Vertebrata; Reproduction; Mammalia; Mouse; Animal; Preoptic nucleus; Development; Estrous cycle; Reproductive cycle; Brain (vertebrata)
• ISSN: 0306-4530; 1873-3360
• DOI: 10.1016/S0306-4530(00)00007-X

Sodium valproic acid (VPA) is a widely prescribed anticonvulsant medication that has been shown to interfere with pubertal maturation of the reproductive system, and induce endocrine abnormalities in adults, within a subset of the clinical population. While VPA's mechanism of action is still poorly understood, it may exert its anti-reproductive effects by enhancing GABAergic inhibition of the GnRH neuronal population within the medial preoptic area (mPOA). The purpose of this study was to determine if chronic administration of VPA alters GABA levels within the mPOA region. In Experiment 1, the mPOA, caudate, and arcuate nucleus regions were harvested from VPA-treated and control mice. Analysis of whole tissue content of GABA revealed that levels were lower in the caudate and arcuate nucleus regions of VPA-treated animals, whereas there were no group differences for the mPOA region. Collapsing across drug group, there was also a trend for males having overall higher levels of GABA as compared to females. In Experiments 2 and 3, mice were implanted with microdialysis probes within the mPOA region and sampled for extracellular GABA levels. Females (Exp. 3) were sampled either on diestrous, proestrous, or estrous. Results from males (Exp. 2) revealed that VPA enhanced extracellular GABA levels in the mPOA region compared with controls. However, GABA levels for both groups remained stable across the sampling period. Conversely, in Exp. 3, females showed cyclical release of GABA across the sampling period. For control females, GABA levels increased during the afternoon on all cycle days, but the rise on proestrus was smaller than on other cycle days. VPA-treated animals showed an overall reduction in GABA levels compared with controls. Furthermore, while GABA increased over sampling time on estrus and diestrus days of the cycle, there was not a significant rise in GABA on proestrus. These data indicate: (1) regional specificity in VPA effects upon GABA levels, (2) a sex difference in the effects of VPA on GABA levels within the mPOA, and (3) GABA levels increase on the afternoon of all days of the estrous cycle with VPA attenuating the rise seen on the afternoon of proestrus. These results provide evidence that VPA effects upon the reproductive axis may involve changes in GABA release, and that males and females show different patterns of neurochemical response to the drug.